Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Active surveillance for intermediate-risk prostate cancer: yes, but for whom?

Overland MR, Washington SL 3rd, Carroll PR, Cooperberg MR, Herlemann A.

Curr Opin Urol. 2019 Aug 20. doi: 10.1097/MOU.0000000000000671. [Epub ahead of print]

PMID:
31436567
2.

Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research.

Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL 3rd, Herlemann A, Carroll PR, Cooperberg MR.

JCO Clin Cancer Inform. 2019 Jul;3:1-8. doi: 10.1200/CCI.18.00084.

3.

Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.

Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR.

Eur Urol Oncol. 2018 Oct;1(5):386-394. doi: 10.1016/j.euo.2018.04.018. Epub 2018 May 24.

PMID:
31158077
4.

Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.

Washington SL 3rd, Neuhaus J, Meng MV, Porten SP.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1339-1344. doi: 10.1158/1055-9965.EPI-18-1280. Epub 2019 May 15.

PMID:
31092404
5.

The Impact of Stone Multiplicity on Surgical Decisions for Patients with Large Stone Burden: Results from ReSKU.

Zetumer S, Wiener S, Bayne DB, Armas-Phan M, Washington SL 3rd, Tzou DT, Stoller M, Chi T.

J Endourol. 2019 Aug 20. doi: 10.1089/end.2019.0130. [Epub ahead of print]

PMID:
31044624
6.

Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance of Early Stage Prostate Cancer.

Cedars BE, Washington SL 3rd, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR.

J Urol. 2019 Apr 8:101097JU0000000000000271. doi: 10.1097/JU.0000000000000271. [Epub ahead of print]

PMID:
30958742
7.

The Association Between Race and Frailty in Older Adults Presenting to a Nononcologic Urology Practice.

Washington SL 3rd, Porten SP, Quanstrom K, Jin C, Bridge M, Finlayson E, Walter LC, Suskind AM.

Urology. 2019 May;127:19-23. doi: 10.1016/j.urology.2019.02.024. Epub 2019 Feb 26.

PMID:
30822479
8.

Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer.

Balakrishnan AS, Washington SL 3rd, Meng MV, Porten SP.

Clin Genitourin Cancer. 2019 Jun;17(3):e461-e471. doi: 10.1016/j.clgc.2019.01.007. Epub 2019 Jan 19.

PMID:
30799130
9.

Health Care Delivery for Metastatic Hormone-sensitive Prostate Cancer Across the Globe.

Herlemann A, Washington SL 3rd, Cooperberg MR.

Eur Urol Focus. 2019 Mar;5(2):155-158. doi: 10.1016/j.euf.2018.12.003. Epub 2018 Dec 23. Review.

PMID:
30587443
10.

Racial distribution of urology workforce in United States in comparison to general population.

Washington SL 3rd, Baradaran N, Gaither TW, Awad MA, Murphy GP, Downs TM, Breyer BN.

Transl Androl Urol. 2018 Aug;7(4):526-534. doi: 10.21037/tau.2018.05.16.

11.

The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma.

Warthan MD, Washington SL, Franzese SE, Ramus RM, Kim KR, York TP, Stratikos E, Strauss JF 3rd, Lee ED.

Biol Reprod. 2018 Mar 1;98(3):309-322. doi: 10.1093/biolre/ioy001.

12.

Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier.

Herlemann A, Washington SL 3rd, Eapen RS, Cooperberg MR.

Urol Clin North Am. 2017 Nov;44(4):547-555. doi: 10.1016/j.ucl.2017.07.003. Review.

PMID:
29107271
13.

Web-Based Physician Ratings for California Physicians on Probation.

Murphy GP, Awad MA, Osterberg EC, Gaither TW, Chumnarnsongkhroh T, Washington SL, Breyer BN.

J Med Internet Res. 2017 Aug 22;19(8):e254. doi: 10.2196/jmir.7488.

14.

Dysregulation of inflammatory gene expression in lesional and nonlesional skin of patients with pyoderma gangrenosum.

Ortega-Loayza AG, Nugent WH, Lucero OM, Washington SL, Nunley JR, Walsh SW.

Br J Dermatol. 2018 Jan;178(1):e35-e36. doi: 10.1111/bjd.15837. Epub 2017 Dec 5. No abstract available.

PMID:
28734003
15.

Increased expression of toll-like receptors 2 and 9 is associated with reduced DNA methylation in spontaneous preterm labor.

Walsh SW, Chumble AA, Washington SL, Archer KJ, Sahingur SE, Strauss JF 3rd.

J Reprod Immunol. 2017 Jun;121:35-41. doi: 10.1016/j.jri.2017.05.003. Epub 2017 Jun 3.

16.

Management of intermediate-risk prostate cancer with active surveillance: never or sometimes?

Masic S, Washington SL 3rd, Carroll PR.

Curr Opin Urol. 2017 May;27(3):231-237. doi: 10.1097/MOU.0000000000000387. Review.

PMID:
28234748
17.

Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.

Eapen RS, Herlemann A, Washington SL 3rd, Cooperberg MR.

Curr Opin Urol. 2017 May;27(3):205-209. doi: 10.1097/MOU.0000000000000383. Review.

PMID:
28221220
18.

Cystoscopic Evaluation of Bladder Leiomyoma.

Washington SL 3rd, Eslami A, Tzou DT.

Urology. 2017 Aug;106:e1-e2. doi: 10.1016/j.urology.2017.01.028. Epub 2017 Feb 1.

PMID:
28161381
19.

Cooperative Clinical Conferences: Nursing Student Pediatric Clinical Innovation.

Waldron MK, Washington SL, Montague GP.

J Nurs Educ. 2016 Jul 1;55(7):416-9. doi: 10.3928/01484834-20160615-12.

PMID:
27351613
20.

Current Use of Imaging after Primary Treatment of Prostate Cancer.

Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR.

J Urol. 2015 Jul;194(1):98-104. doi: 10.1016/j.juro.2015.01.097. Epub 2015 Jan 30.

PMID:
25640648
21.

Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort.

Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR.

Urology. 2014 Jan;83(1):33-8. doi: 10.1016/j.urology.2013.05.070. Epub 2013 Nov 15.

PMID:
24246319
22.

Out-of-pocket fertility patient expense: data from a multicenter prospective infertility cohort.

Wu AK, Odisho AY, Washington SL 3rd, Katz PP, Smith JF.

J Urol. 2014 Feb;191(2):427-32. doi: 10.1016/j.juro.2013.08.083. Epub 2013 Sep 7.

PMID:
24018235
23.

Benign prostate glandular tissue at radical prostatectomy surgical margins.

Odisho AY, Washington SL 3rd, Meng MV, Cowan JE, Simko JP, Carroll PR.

Urology. 2013 Jul;82(1):154-9. doi: 10.1016/j.urology.2012.12.063. Epub 2013 Mar 21.

24.

Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.

Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR.

BJU Int. 2012 Jul;110(1):50-5. doi: 10.1111/j.1464-410X.2011.10704.x. Epub 2011 Nov 11.

25.

Management for prostate cancer treatment related posterior urethral and bladder neck stenosis with stents.

Erickson BA, McAninch JW, Eisenberg ML, Washington SL, Breyer BN.

J Urol. 2011 Jan;185(1):198-203. doi: 10.1016/j.juro.2010.09.020. Epub 2010 Nov 13.

26.

A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy.

Washington SL 3rd, Shindel AW.

Drug Des Devel Ther. 2010 Sep 7;4:159-71. Review.

27.

Neutrophil expression of cyclooxygenase 2 in preeclampsia.

Bachawaty T, Washington SL, Walsh SW.

Reprod Sci. 2010 May;17(5):465-70. doi: 10.1177/1933719110361960. Epub 2010 Mar 10.

28.

A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo.

Zhang X, Smith DL, Meriin AB, Engemann S, Russel DE, Roark M, Washington SL, Maxwell MM, Marsh JL, Thompson LM, Wanker EE, Young AB, Housman DE, Bates GP, Sherman MY, Kazantsev AG.

Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):892-7. Epub 2005 Jan 10.

29.

A genetic system to identify DNA polymerase beta mutator mutants.

Washington SL, Yoon MS, Chagovetz AM, Li SX, Clairmont CA, Preston BD, Eckert KA, Sweasy JB.

Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1321-6.

30.
31.

Hyperplastic nodules after portacaval anastomosis in rats.

Weinbren K, Washington SL.

Nature. 1976 Dec 2;264(5585):440-2. No abstract available.

PMID:
1004573
32.

The response of the rat liver to alterations in total portal blood flow.

Weinbren K, Washington SL, Smith CY.

Br J Exp Pathol. 1975 Apr;56(2):148-56.

33.

The effects of starvation on the proliferative response after partial hepatectomy.

Stirling GA, Laughlin J, Washington SL.

Exp Mol Pathol. 1973 Aug;19(1):44-52. No abstract available.

PMID:
4721723
34.

The development of a proliferative response in liver parenchyma deprived of portal blood flow.

Weinbren K, Stirling GA, Washington SL.

Br J Exp Pathol. 1972 Feb;53(1):54-8. No abstract available.

35.

Critical cytoplasmic mass and the initiation of the proliferative response in the rat liver.

Weinbren K, Stirling GA, Washington SL, Hooper SB, Laughlin J.

Br J Exp Pathol. 1971 Oct;52(5):583-8. No abstract available.

Supplemental Content

Loading ...
Support Center